Terminated MDLs: 2026

Long-running litigation involving defective drywall imported from China that released sulfur compounds, causing corrosion of metal components, electrical failures, and health issues in homes. Most claims were resolved through settlements with manufacturers and suppliers over the course of the litigation.

Antitrust litigation alleging major banks conspired to manipulate the London Interbank Offered Rate (LIBOR), affecting trillions of dollars in financial instruments. Multiple settlements were reached with defendant banks over the years, with the final remaining matters resolved.

Privacy litigation alleging TikTok collected and shared users' personal data without consent, including biometric data and information from minors. The case was resolved through a class action settlement providing compensation to affected users.

Wrongful death and personal injury claims arising from the crash of Sriwijaya Air Flight 182 into the Java Sea shortly after takeoff from Jakarta, killing all 62 people on board. Claims were resolved through settlements with Boeing and the airline.

Patent litigation related to the Xarelto blood thinner, involving disputes over the '310 patent. This companion MDL to the products liability case has been terminated following resolution of remaining patent disputes.

Class action litigation arising from a cyberattack on Evolve Bank & Trust that compromised customer personal information. Evolve agreed to an $11.85 million settlement providing affected class members with credit monitoring, reimbursement of up to $3,000 for documented losses, and a flat cash payment. Settlement payments were issued in March 2026.

Litigation alleging that SoClean's ozone-based CPAP cleaning devices posed respiratory health risks and that the company made misleading marketing claims about the safety and efficacy of its products. Consumer claims were largely resolved through dismissals and settlements, with only 2 cases remaining at the time of termination. A related cross-claim by Philips seeking contribution toward its own CPAP settlement was severed into a separate civil action.

Antitrust litigation alleging that major tire manufacturers conspired to fix prices for passenger vehicle replacement tires sold in the United States. Plaintiffs alleged coordinated price increases and information sharing among defendants. The JPML closed the MDL on April 3, 2026.

Antitrust litigation alleging that Jazz Pharmaceuticals engaged in anticompetitive conduct to delay generic competition for Xyrem (sodium oxybate), a narcolepsy medication. Plaintiffs alleged Jazz used reverse-payment patent settlements with generic manufacturers and abuse of FDA processes to maintain monopoly pricing. The JPML closed the MDL on April 21, 2026.

Patent litigation concerning a liquid toppings dispensing system (the '447 patent). The small docket wound down through the consolidated proceedings; the JPML closed the MDL on June 18, 2026.

Patent litigation involving SAP SE and related defendants. The small docket (4 actions) wound down through the consolidated proceedings; the JPML closed the MDL on July 10, 2026.

Patent litigation brought by Midwest Energy Emissions Corp. (ME2C) over mercury-emissions-control technology, centralized in the Southern District of Iowa on December 12, 2024. The small docket (7 total actions) wound down through the consolidated proceedings; the JPML closed the MDL on August 17, 2026.

Hatch-Waxman patent litigation in which AbbVie and Allergan alleged that generic manufacturers Fresenius Kabi and Qilu (with Apotex) infringed patents covering the antibiotic AVYCAZ (ceftazidime-avibactam) by seeking FDA approval of generic versions. Both actions were dismissed by stipulated orders in August 2026, with terms not publicly disclosed, and the JPML closed the MDL on September 2, 2026.

Consumer privacy litigation alleging Google circumvented default privacy settings in the Safari and Internet Explorer browsers to place tracking cookies in 2011 and 2012. A $5.5 million cy pres class settlement was vacated by the Third Circuit in 2019, and a revised settlement failed final approval in 2023. On August 27, 2026 the court denied class certification; the named plaintiffs then stipulated to dismissal, and the JPML closed the MDL on September 3, 2026.

Products liability litigation alleging Smith & Nephew's metal-on-metal Birmingham Hip Resurfacing system shed metal debris, causing metallosis and revision surgeries; a total hip arthroplasty track was later added. Smith & Nephew negotiated confidential settlements for groups of cases, and in 2022 the court set up a mediated aggregate-settlement process for the remaining cases. Settlement amounts were not made public. With no actions pending all of 2026, the JPML closed the MDL on September 28, 2026.

Consumer class actions alleging Evenflo misled buyers by marketing its "Big Kid" booster seats as side-impact tested and suitable for children as light as 30 pounds; Evenflo denied wrongdoing. The court granted final approval on February 25, 2026 to a $3.5 million nationwide class settlement that pays a pro rata cash share plus a $25 Evenflo credit for each claimed seat, and the JPML closed the MDL on September 30, 2026.